Astell units sterilise contaminated lab waste

Published: 9-Jun-2010
Manufacturing Sustainability Regulatory

Astell markets liquid waste treatment plants for Category 3 and 4 labs

Autoclave and steriliser manufacturer, Astell, has introduced a range of contaminated liquid waste containment and treatment plants for Category 3 and 4 laboratories, including veterinary and medical research, pharmaceutical manufacturing and healthcare.

Current legislation requires that all waste water from sinks, washrooms, sanitary installations and similar facilities within these designated areas have to be sterilised prior to discharge to sewer. The Astell units cover capacities from 100 to 5000 litres of liquid waste per day.

In the standard batch processing unit, liquid waste is collected in a stainless steel jacketed containment tank. When the radar level controller detects that the tank is full, the heat sterilisation sequence starts automatically.

Heating is by steam supplied either from the unit’s integral steam generator or from an external source. Once the sequence is complete, the sterilised effluent is discharged to sewer using compressed air.

Continuous processing units are provided with two tanks. The first tank is filled as in the batch operation, and commences sterilisation. Influent liquid waste is then diverted to the second tank. When the sterilisation sequence is complete, the tank remains idle until the second tank is full. In this way effluent collection is continuous so there is no delay to laboratory operations.

Each tank is fully contained and all connections are above liquid level eliminating dangerous and costly leaks. A vent filter ensures that no microbial contaminants can be discharged with air or vapour. Access to the fully programmable controller is via Astell’s PIN protected, full colour touch screen which displays cycle information and has facilities for data archiving and ethernet monitoring.

Astell offers full project assistance including an initial site survey to ascertain the volume of waste and advise the best treatment method, detailed engineering proposals, manufacture, delivery and installation of the equipment and IQ and OQ validation packages.

See more

You may also like

Containment

Biocontainment facilities: Down the drain

Read more
Graham Scarr, Technical Director of AstellBio, discusses approaches to effluent decontamination in containment level 2 and level 3 facilities

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    NICE approval is not enough: why the UK’s next medicines challenge is operational delivery A medicine is not truly accessible until it can be manufactured, procured, stocked, prescribed, dispensed and delivered reliably. That distinction is becoming increasingly important, says Varun Cruz, founder of NEUVIOR
  2. Compact, economical and sustainable cooling solutions for laboratories Huber Unichillers offer space-saving and environmentally friendly temperature control for research and industrial applications
  3. Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months
  4. Bruker announces major strides in 4D proteomics performance, further advances In intact and top-down functional proteoform analysis, and innovations in hybrid qual/quant 4D metabolomics All to enable deeper insights into disease biology. Bruker Also Launches Two Novel Mass Spectrometry Systems for Unique Applications in Energy Industry Research, and in Semiconductor Manufacturing

Upcoming event

BIO International Convention

22–25 June 2026 | Convention | Boston, US See all

You may also like

Containment

Biocontainment facilities: Down the drain

Graham Scarr, Technical Director of AstellBio, discusses approaches to effluent decontamination in containment level 2 and level 3 facilities
Manufacturing

Astell helps the fight against cancer

Astell Scientific, the UK’s leading supplier of autoclaves, is helping to ensure the safety and reliability of laboratory work at Barts Cancer Institute, Queen Mary University of London
Manufacturing

Astell expands steam generator range

Free-standing models designed with peak demand in mind
Regulatory

E for Essential

E range autoclaves from Astell offer a small price tag and a small footprint
Regulatory

AMR Bio urges US policymakers to make infection prevention a core AMR strategy

Submitted ahead of PACCARB's 27th public meeting, AMR Bio's recommendations call for topical antimicrobials such as MRSA-active XF-73 to receive federal support alongside conventional antibiotic development
Manufacturing

Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference

By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence
Manufacturing

Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration

CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months
Subscribe now